Mirum Pharmaceuticals Files Form 4
Ticker: MIRM · Form: 4 · Filed: Apr 17, 2026
Sentiment: neutral
Topics: insider-trading, ownership-change
TL;DR
Mirum Pharma insiders changed their stock holdings on 4/15.
AI Summary
On April 15, 2026, Mirum Pharmaceuticals, Inc. reported changes in beneficial ownership of securities. The filing, dated April 16, 2026, details transactions related to the company's stock.
Why It Matters
Form 4 filings disclose changes in ownership by company insiders, providing insights into their confidence in the company's prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of insider stock transactions and does not inherently indicate increased risk.
Key Numbers
- 2026-04-15 — Period of Report (Date of reported ownership change)
- 2026-04-16 — Filing Date (Date the form was officially filed)
Key Players & Entities
- Mirum Pharmaceuticals, Inc. (company) — Issuer
- Ramasastry Saira (person) — Reporting Person
FAQ
What type of filing is this?
This is a Form 4 filing, a Statement of changes in beneficial ownership of securities.
Who is the issuer of this filing?
The issuer is Mirum Pharmaceuticals, Inc.
What is the accession number for this filing?
The SEC Accession No. is 0001547959-26-000007.
When was the period of report for this filing?
The period of report was April 15, 2026.
Who is listed as a reporting person in this filing?
Ramasastry Saira is listed as a reporting person.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 17, 2026 by Ramasastry Saira regarding Mirum Pharmaceuticals, Inc. (MIRM). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.